Immunovaccine's Angel Round

Immunovaccine raised a round of funding on , . Investors include First Angel Network.

IMV develops cancer immunotherapies and infectious disease vaccines based on the Company's DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and a…

Articles about Immunovaccine's Angel Round: